15. Kriegler, M. , Perez, C. , DeFay, K. , Albert, I. and Lu, S.D. A novel 
form of TNF/cachectin is a cell surface cytotoxic transmerabrane protein: 
ramifications for the complex physiology of TNF. Cell 53:45-53, 1988. 
16. Spriggs, D.R. , Sherman, M.L., Michie, H. , Arthur, K.A., Imaraura , K. , 
Wilmore, D. , Frei, E. , Kufe, D.W.: Recombinant human tumor necrosis factor 
administered as a 24-hour intravenous infusion. A phase I and pharmacologic 
study. J. Natl. Cancer Inst. 80:1039-1044, 1988. 
17. Sherman, M.L., Spriggs, D.R. , Arthur, K.A. , Imamura , K. , Frei, E., and 
Kufe, D.W.; Recombinant human tumor necrosis factor administered as a 
five-day continuous infusion in cancer patients: Phase I toxicity and 
effects on lipid metabolism. J. Clin. Oncol . 6:344-350, 1988. 
18. Feinberg, B, Kurzrock, R. , Talpaz, M. , Blick, M. , Saks, S. and Gutterman, 
J.U.: A phase I trial of intravenously^administered recombinant tumor 
necrosis factor-alpha in cancer patients. J. Clin. Oncol. 6:1328-1334, 
1988. 
19. Moritz, T. , Niederle, N. , Baumann, J., May, D. , Kurschel, E. , Osieka, R. , 
Kempeni, J. , Schlick, E. and Schmidt, C.G.: Phase I study of recombinant 
human tumor necrosis factor alpha in advanced malignant disease. Cancer 
Immunol. Immunother . 29:144-150, 1989. 
20. Bartsch, H.H., Pfizenmaier, K., Schroeder, M. and Nagel, G.A.: Intralesional 
application of recombinant human tumor necrosis factor alpha induced local 
tumor regression in patients with advanced malignancies. Eur. J. Cancer 
25:287-281, 1989. 
21. Kahn, J. , Kaplan, L., Ziegler, J., Volberding, P., Crowe, S. , Saks, S., and 
Abrams, D.: Phase II trial of intralesional recombinant tumor necrosis 
factor alpha (TNF) for AIDS associated Kaposi's sarcoma (KS). Proc. ASCO 
8:4, 1989. 
[286] 
Recombinant DNA Research, Volume 14 
